major challenges of glycomics are to characterize a glycome and identify functional glycans as ligands for glycan-binding proteins (GBPs). to address these issues we developed a general strategy termed shotgun glycomics. We focus on glycosphingolipids (Gsls), a class of glycoconjugates that is challenging to study, recognized by toxins, antibodies and GBPs. We derivatized Gsls extracted from cells with a heterobifunctional fluorescent tag suitable for covalent immobilization. We separated fluorescent Gsls by multidimensional chromatography, quantified them and coupled them to glass slides to create Gsl shotgun microarrays. then we interrogated the microarrays with cholera toxin, antibodies and sera from individuals with lyme disease to identify biologically relevant Gsls that we subsequently characterized by mass spectrometry. shotgun glycomics incorporating Gsls and potentially glycoprotein-derived glycans is an approach for accessing the complex glycomes of animal cells and is a strategy for focusing structural analyses on functionally important glycans.
Biologically important glycans found in glycosphingolipids and glycoproteins [1] [2] [3] [4] comprise the complex glycomes of cells and tissues. They are recognized by glycan-binding proteins (GBPs) expressed in human and animal cells, pathogens and antibodies developed against host and foreign glycans [5] [6] [7] . Despite enormous progress in high-performance liquid chromatography (HPLC), lectin affinity chromatography, mass spectrometry and glycan microarrays 8, 9 , chemically defining a glycome, the complete list of glycan structures that occur in a cell, tissue or organism, remains elusive.
Because glycan structural analyses are difficult and require specialized technologies, a means of focusing analyses on biologically relevant glycans is desired. As practical exploration of a cellular glycome should also incorporate quantitative and functional information about glycans, we devised the strategy of 'shotgun glycomics' . We derivatized glycans from cellular glycosphingolipids (GSLs) to generate fluorescently labeled glycans that can be separated, quantified and covalently printed on glass slides or other surfaces for interrogation by GBPs and antibodies ( Fig. 1) . This approach, which potentially also can be used to incorporate glycoprotein-derived glycans, is comparable in some ways to shotgun genomics, as the ultimate goal is the elucidation of structures (sequence) and functions of the glycome or genome.
We developed a fluorescent tag N-(aminoethyl)-2-amino benzamide (AEAB) with an available aryl amine for conjugation to free glycans and an alkyl amine for efficient conjugation to reactive surfaces 10 . However, a major hurdle to shotgun glycomics and functional glycomics in general is derivatization of GSLs. Glycans of GSLs are linked to a sphingosine moiety 11 , and although enzymatic release of the glycans from GSLs is feasible 12 , the complete loss of the aglycone may compromise GBP recognition. Therefore, we developed an approach for fluorescently labeling GSLs that permits easy derivatization, quantification, separation by HPLC and immobilization to glass slides to generate GSL shotgun microarrays. These microarrays allow interrogation by GBPs and antibodies, permitting structural analyses of GSLs recognized by GBPs. results ozonolysis, fluorescence conjugation and printing of Gsls Ozonolysis of the common sphingosine moiety in GSLs generates a free aldehyde, readily reactive with the heterobifunctional p-nitrophenyl anthranilate (PNPA) 13 through reductive amination to form a GSL-PNPA derivative, bearing a p-nitrophenyl ester as an excellent leaving group (Fig. 2a) . The derivative precipitates from the product mixture with acetonitrile and, upon reaction with diamines, transforms to a fluorescent GSL derivative, which retains an alkyl amine that can be covalently coupled to appropriate surfaces.
We evaluated and optimized this approach using the monosialyl ganglioside GM1 (Galβ1-3GalNAcβ1-4(Neu5Acα2-3) Galβ1-4Glcβ1-ceramide) (Supplementary Fig. 1 ). We chose N-hydroxysuccinimide (NHS)-activated slides for subsequent studies because of their generally lower background and ozone, PNPA and octane-1,8-diamine (ODA) derivatization with its C 8 extension, owing to its relatively higher sensitivity of detection on microarrays. We evaluated this procedure with other GSLs, including the compounds named GD1a and GT1b and a mixture of bovine brain gangliosides (BBG) (Fig. 2b-d) . C 18 -HPLC profiles (Fig. 2b) of the products from GM1, GD1a and GT1b each showed a dominant fluorescence peak, suggesting that the reactions were highly specific. No substantial desialylation occurred for individual gangliosides or BBG mixture based on HPLC. We purified all products by HPLC and characterized them by matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) spectroscopy (Fig. 2c) and confirmed all expected masses. We observed partial losses of sialic acids in the MALDI, especially for multisialylated gangliosides.
To ensure that precipitation of GSL-PNPA in acetonitrile after reductive amination was quantitative, we treated the filtrate, precipitate and crude reductive amination product without precipitation with a large excess of ODA (Fig. 2d) . Comparison of HPLC profiles of the products indicated that the precipitation was complete. We then compared the underivatized GSLs and GSL-AOAB products using thin-layer chromatography (TLC). We detected both underivatized GSLs and the GSL-AOAB products with orcinol staining, whereas only the AOAB derivatives showed fluorescence under UV light (Supplementary Fig. 2 ). The orcinol staining suggested the nearly quantitative AOAB derivatization, as the TLC profiles after derivatization did not show more complexity. The fluorescent nature of the derivatives greatly facilitated preparative TLC and TLC protein overlay without destructive chemical staining.
shotgun Gsl microarray generated from BBG mixture We treated the BBG mixture with ozone, PNPA and ODA, and separated the AOAB-labeled mixture of fluorescent GSLs from excess reagents by semipreparative C 18 HPLC and then fractionated it by two-dimensional HPLC ( Supplementary  Fig. 3 ). The normal phase columns retain GSL-AEABs via their glycan moieties and provide good separation. The normal phase fractions are resolved in a second dimension by reverse-phase HPLC, which simultaneously desalts each of the normal phase fractions. The resolved GSL-AOAB derivatives comprise the tagged glycolipid library (TGL) and have a free alkyl-amine function for printing as a GSL microarray and subsequent mass spectrometry characterization. We quantified, characterized and printed equimolar concentrations (10 µM) of material from the recovered peaks on NHS slides. This BBG microarray contains 40 GSL-AOAB fractions plus controls. The compositional information of these fractions from MALDI-TOF/TOF was generated in an automatic fashion (Supplementary Table 1 ). We interrogated this GSL shotgun microarray with biologically relevant GBPs: cholera toxin subunit B (CTSB) (Fig. 3a) and antibody to GD1a (anti-GD1a) (Fig. 3b) . These GBPs primarily bound GSLs in fractions 9 and 24, respectively. We characterized the glycan structures in these fractions by mass spectrometry and tandem mass spectrometry (MS/MS) (Fig. 3c,d) . The parent ions matched the expected compositions, which we analyzed by collision-induced dissociation MS/MS for a more detailed structural analysis. The loss of labile N-acetylneuraminic acid (Neu5Ac; -291 Da) gave abundant fragment ions. Furthermore, the sequential loss of hexose (Hex; -162 Da), N-acetylhexosamine (HexNAc; (-203 Da), Hex (-162 Da), Hex (-162 Da) in the MS/MS spectra of fractions 9 and 24 is consistent with the structure asialo-GM1, Galβ1-3GalNAcβ1-4Galβ1-4Glcβ1-R, confirming the general ganglioside core structure. The fragment ion at m/z of 1,248 (1,247 for fraction 24) identified Neu5Ac-Gal-Glcceramide-AOAB and excluded the possibility of other isomers, such as GM1b and GD1b. The results allow the predictions that fraction 9 was GM1-AOAB, whereas fraction 24 was GD1a-AOAB (Neu5Acα2-3Galβ1-3GalNAcβ1-4(Neu5Acα2-3)Galβ1-4Glcβ1-R). Anti-GD1a also cross-reacted with material in fractions 8, 22, 26 and 30. This result highlights the value of the GSL shotgun microarray to explore specificities of monoclonal antibodies.
serum antibody binding to shotgun Gsl microarray
To evaluate the general utility of this approach using the BBG microarray, we screened for antibodies to GSLs (anti-GSL) in serum from individuals diagnosed with Lyme disease (Fig. 4a,b and Supplementary Table 2) . Studies show a variety of peripheral neuropathies 14 , including those linked with Lyme disease 15 , are associated with antibodies to gangliosides. Although both control sera and sera from individuals with Lyme disease showed comparable weak binding to several gangliosides, only one BBG fraction (fraction 12) showed significant recognition by sera from individuals with Lyme disease (P < 0.05) compared to control sera (Fig. 4b) . Out of ten sera from individuals with Lyme disease, five had a relatively high immunoglobulin gamma (IgG) response (>100 normalized relative fluorescence units (RFUs)), and two had medium IgG responses (50-100 normalized RFUs) against fraction 12. Only one of eight control sera had a high IgG response, and one had a medium IgG response against fraction 12 (Supplementary Table 2 ). We analyzed the MS and MS/MS data of fraction 12 ( Fig. 4c) , which suggested a composition of (Hex) 3 (HexNAc) 1 (Neu5Ac) 2 -H 2 O. MS/MS analysis confirmed the composition with a clear Hex-Hex-HexNAcHex pattern, consistent with a ganglioside tetrasaccharide. The neutral loss of H 2 O may have occurred during ioznization, but the considerably shorter retention time (34.76 min) of this derivative compared to that for a standard GD1a-AOAB (40.46 min) on normal phase HPLC suggests lower hydrophilicity, which might result from dehydration in the molecule. Although fraction 12 is a disialyl ganglioside, its MS/MS pattern is dramatically different from that of GD1a-AOAB, another disialyl ganglioside (Fig. 3d) . There was an abundant fragment ion at m/z of 1,321.4 from loss of two Neu5Ac molecules (Neu5Ac 2 -H 2 O), but we observed absolutely no fragment ion owing to loss of one Neu5Ac, suggesting another linkage between the two Neu5Ac moieties besides the common α2,8 glycosidic bond, possibly through formation of an internal ester or anhydro-ether bond. Furthermore, the fragment ion at m/z of 1,521.9, owing to loss of HexNAc-Hex without loss of Neu5Ac, indicated no terminal Neu5Ac attached to the far-most galactose at the nonreducing end and suggests a structure closely related to GD1b. Subsequent studies, including comparison with GD1b-AOAB prepared from standard, neuraminidase resistance, and formation of an amide with ethylenediamine, strongly supported the prediction that fraction 12 was GD1b-lactone ( Supplementary Fig. 4 ). GD1b-lactone has been identified in brain tissues and melanoma cells 16, 17 . It can also be generated under acidic conditions in vitro 18 . Additional study is now warranted with a larger set of serum samples from individuals with Lyme disease and controls. These results demonstrate the power of shotgun glycomics in identifying a relevant but unusual and relatively low-abundance GSL in the mixture of starting material.
shotgun glycomics of Gsls from erythrocytes and Pc3 cells
To explore the general applicability of this method using whole cells, we prepared GSL-AOABs from human erythrocytes of blood types O and A. Human erythrocytes contain minute amounts of GSLs expressing blood group antigens, as most blood group antigens are found in glycoproteins 19 . We extracted GSLs from erythrocyte ghosts and derivatized them with AOAB. The C 18 -HPLC profiles of O-and A-erythrocyte GSL-AOAB were similar (Fig. 5a,b) . The TGL of O-erythrocyte GSL-AOAB and A-erythrocyte GSL-AOAB were comprised of 23 and 25 fractions, respectively. After separation and quantification, we printed and interrogated the TGL shotgun arrays with several GBPs. Binding by Aleuria aurantia lectin, specific for α-linked fucose, suggested the general occurrence of fucose (Fig. 5c) , whereas binding of several fractions by Ulex europaeus agglutinin I, specific for α1-2 fucose, in both O-erythrocytes and A-erythrocytes (Fig. 5d ), indicated the occurrence of H antigen in both blood types. Helix pomatia agglutinin, specific for terminal α-GalNAc and antibody to blood group A, only bound several GSL-AOAB fractions prepared from A-erythrocytes with no cross-reactivity to O-erythrocyte GSL-AOAB fractions (Fig. 5e,f) . In future studies, we will explore the blood group structures of such GSLs recognized by these specific antibodies. Many antibodies and other GBPs recognize tumor cells and may be useful in diagnostics and therapeutics. Therefore, we tested the shotgun glycomics approach with the cultured prostate cancer cell line PC3, which has been used for immunizations to develop antibodies that may have therapeutic potential and recognize undefined glycolipid antigens 20 . Using 1 × 10 7 PC3 cells, we prepared the mixture of GSL-AOAB derivatives as described above from GSLs extracted from the whole-cell pellet. The C 18 -HPLC profile (Supplementary Fig. 5a ) was quite different from that of erythrocytes (Fig. 5a,b) . We collected 33 fractions, printed them on a microarray and assayed them with several plant lectins (Supplementary Fig. 6 ), which revealed differential binding to different fractions and controls. We characterized 10 major fractions by MALDI-TOF/TOF (Supplementary Table 3) . Overall, the results predicted that sulfated globosides (HexNAc-Hex-HexHex-ceramide) were the major structures in PC3 GSL-AOABs, along with sialylated globosides (Supplementary Table 3) . To illustrate the sulfated globoside structure of the PC3 GSLs, we analyzed one fraction (fraction 16) (Supplementary Fig. 5b) . The MS and MS/MS analyses using both positive and negative modes suggest a globo-series GSL structure with a sulfated pentasaccharide glycan. The GSL-AOAB fractions can be processed in a second dimension to generate individual glycans, whose composition can be determined by MS and MS/MS and printed as a microarray to explore the specificities of antibodies to PC3 cells, such as the F77 antibody 20 that is presumably directed to glycolipid epitopes.
discussion
The shotgun glycomics approach complements our recently developed strategies for derivatizing N-and O-glycans released from glycoproteins using either non-reductive or reductive labeling with the fluorescent bifunctional AEAB reagent for separating and attaching glycans 10, 21 . Glycans releasable from glycoproteins together with cellular GSLs can now be analyzed in a shotgun format for studies on recognition by GBPs, including antibodies and toxins. GSLs and N-and O-glycans of cells can all be derivatized with similar 2-aminobenzamide-based fluorescent tags, which also permits purification and covalent coupling through similar chemistries for all classes of cellular glycans. Thus, the cellular glycome can be functionally analyzed before focused sequencing approaches on relevant glycans. Shotgun microarrays prepared from natural sources complement and enlarge existing defined glycan microarrays, which are mainly comprised of chemically and/or enzymatically prepared glycans 22 . TGLs prepared using the shotgun approach are a permanent repository of a particular glycome and are available for detailed structural analysis or may be used for printing additional glycan arrays or coupling the glycans to other solid surfaces to assess interactions with novel GBPs. As the structures in a TGL are defined, so is the glycome of the cells or tissues used for its preparation, providing a strategy for expanding the number of structures on defined glycan arrays.
Here we analyzed GSLs, which are challenging to study because of their amphipathic nature and a lack of sensitive chromophores for detection. In most cases, strategies for detection and quantification of GSLs use destructive chemical sprays on TLC or relatively insensitive absorbance approaches 23 . In previous approaches to overcome the poor detection sensitivity during HPLC separation of GSLs, the component glycans had been released from lipid and analyzed as fluorescent glycans by HPLC 24, 25 , but this provided no capability to explore their recognition by GBPs. Historically, studies on recognition of GSLs by various GBPs have been complex and often based on separation of GSLs by TLC and overlay with GBPs or immunoassay-type formats 26, 27 . Neo-glycolipids have been previously generated from free glycans and printed on microarrays to study the glycan recognitions by GBPs 28 . These neo-glycolipids, however, are unrelated to natural GSLs as we describe in this study.
Ozonolysis, previously used to release oligosaccharides or conjugate sugars to reactive surfaces 29 , is specific to unsaturated bonds, as typically occur in sphingosine 30 , and permits easy fluorescent derivatization by PNPA and subsequently diamines. We have demonstrated the utility of bifunctional fluorescent tags to label free reducing glycans with diaminopyridine 31, 32 , AEAB 10, 21 and PNPA 13 , to generate glycoconjugates with a functional amino group for subsequent immobilization on reactive surfaces. By exploiting the alkene present in the sphingosine moiety of most GSLs, we modified and adapted the PNPA-diamine labeling procedure for glycomic analysis of GSLs. In shotgun glycomics, the fractions are printed at equimolar concentrations on a microarray, which is interrogated with biologically relevant GBPs, so that structural analyses will be focused on only those glycans recognized by the GBP. Thus, with only nanomolar amounts of GSL-AOAB purified from natural sources, it is possible to study the binding properties of proteins or microorganisms to different GSL-AOABs by microarray technology.
Our studies indicate that sera from individuals with Lyme disease (borreliosis) express antibodies to glycolipids. Lyme disease is initiated from a bacterial infection with Borrelia burgdorferi, but the pathogenesis is believed to be related to auto-antibodies to glycolipids 15, 33 . Our observed IgG response to a disialylated ganglioside GD1b-lactone in the BBG mixture presumably arose from cross-reactivity of the IgG generated against the bacterial glycoconjugates present during the infection, as glycolipid antigens are known to be present in B. burgdorferi 33, 34 . The characterization of GD1b-lactone provides a structural hint for future studies on the pathogenesis of Lyme disease, and more detailed analyses of such epitopes may lead to the development of diagnostic methods and therapeutic reagents. Similarly, GSL microarrays and TGLs prepared from human erythrocytes and PC3 cells indicate that our approach may be especially useful in identifying antibodies to carbohydrates 20 of human tumors and could be important in biomarker discoveries for diagnostics and treatments. nAture methods online methods Reagents and instrumentation. Ganglioside standards were purchased from Calbiochem and stored at −20 °C until use. All chemicals were purchased from Sigma-Aldrich and used without further purification. HPLC solvents were purchased (Fisher Scientific). An Ultraflex-II TOF/TOF system (Bruker Daltonics) was used for MALDI-TOF mass spectrometry analysis. Both reflective positive and reflective negative modes were used as indicated in the figures. The 2,5-dihydroxybenzoic acid (5 mg ml −1 in 50% acetonitrile, 0.1% TFA) was freshly prepared as the matrix. We spotted 0.5 µl matrix solution on an Anchorchip target plate (200 µm or 400 µm) and air-dried. Then 0.5 µl solution was applied and air-dried. An ozone generator (model OZV-8, Ozone Solutions) was used to generate ozone from high purity oxygen. Serum samples with a positive diagnosis for Lyme disease and control sera were obtained from Emory University Clinical Laboratory (Institutional Review Board approval number 00001614). PC3 cells (American Type Culture Collection (ATCC) CRL-1435) were grown in T-medium supplemented with 10% FBS and 5% pen-strep (Invitrogen). Confluent PC3 cells were trypsinized, pelleted and stored at −80 °C until use.
Extraction of GSLs from cells.
The extraction and desalting of GSLs from cells essentially followed protocols described previously 35 . Erythrocyte ghosts were prepared from ~300 ml each of A-type blood and O-type blood. Whole PC3 cell pellet (~0.5 ml; cell count, ~5 × 10 7 ) was directly processed as described below. The wet human erythrocyte ghost pellet (or PC3 whole cell pellet) was homogenized with 3 volumes of water using a tip sonicator. The homogenate was added to 10.7 volumes of methanol slowly with stirring followed by 5.3 volumes of chloroform so that the final solvent ratio is 4:8:3 (C:M:W). The mixture was stirred for 30 min and centrifuged at 8,000g for 30 min. The supernatant was poured into a separation funnel and 0.173 volume (relative to the supernatant) of water was slowly added. After gentle mixing, the upper phase was isolated. The upper phase was desalted with C18 Sep-pak, evaporated and re-dissolved in 2:1 chloroform-methanol (v/v) for AOAB labeling.
Ozonolysis and fluorescent labeling of GSLs. GSLs (0.1-10 mg) were dissolved in 1-2 ml 2:1 chloroform-methanol (v/v) and chilled in a dry ice-acetone bath. Ozone freshly generated by the ozone generator was passed through the solution for 1 min while the blue color persisted. Nitrogen was bubbled through the solution for 1 min to remove the excess ozone. Methyl sulfide (Me 2 S), 100 µl, was added to destroy residual ozone, and after standing for 1 h at room temperature (22 °C), the solution was dried under a stream of nitrogen. The ozonolysis products were labeled with PNPA as described previously for free glycans 13 . Briefly, 0.35 M PNPA and 1 M NaCNBH 3 in mixed solvent of dimethyl sulfoxide (DMSO) and acetic acid (AcOH) (7:3 v/v) were freshly prepared, and an equal amount (20 to 200 µl) of each solution was added to the dried residue and heated at 65 °C for 2 h. Acetonitrile (10 volumes) was added and the mixture was cooled at −20 °C for 2 h. The mixture was centrifuged and the supernatant was removed. To the precipitated GSL-PNPA derivatives, ODA (10% in DMSO, 20 to 200 µl) was added and the suspension was mixed on a vortex mixer for 30 min followed by the addition of 20 to 200 µl of 10% acetic acid. The mixture was centrifuged, and the product was obtained from the supernatant. HPLC analysis. An HPLC CBM-20A system (Shimadzu), coupled with a UV-light detector (SPD-20A) and a fluorescence detector (RF-10Axl), was used for HPLC analysis and separation of GSL-AOABs. UV-light absorption at 330 nm or fluorescence at 330 nm excitation and 420 nm emission was used to detect GSL-AOABs in HPLC analyses and separations. Both UV-light absorption and fluorescence intensity were used for the quantification of GSLs with LNnT-AEAB as a standard.
For normal phase HPLC separation, a Zorbax NH 2 column (250 mm × 4.6 mm) was used for analysis and a semi-preparative Zorbax NH 2 column (250 mm × 9.2 mm) was used for preparative separations. The mobile phase used was acetonitrile, water and 250 mM ammonium acetate (pH 4.5). In the analytical run, the concentration of water increased from 20% to 50% and the concentration of ammonium acetate buffer increased from 0 mM to 50 mM linearly over 25 min. In the preparative run, the concentration of water increased from 10% to 90% and the concentration of ammonium acetate buffer increased from 0 mM to 100 mM linearly over 120 min. For reverse phase HPLC with C18 column, a Vydac C18 column (250 mm × 4.6 mm) was used. The mobile phase was acetonitrile and water with 0.1% trifluoroacetic acid (TFA). The concentration of acetonitrile increased from 15% to 90% linearly over either 37.5 or 75 min.
